Cargando…
Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience
In vitro studies have demonstrated that cancer-specific T cell cytotoxicity can be induced both ex vivo and in vivo, but this therapeutic strategy should probably be used as an integrated part of a cancer treatment regimen. Initial chemotherapy should be administered to reduce the cancer cell burden...
Autores principales: | Liseth, Knut, Ersvær, Elisabeth, Hervig, Tor, Bruserud, Øystein |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896720/ https://www.ncbi.nlm.nih.gov/pubmed/20625438 http://dx.doi.org/10.1155/2010/692097 |
Ejemplares similares
-
Intensive chemotherapy for acute myeloid leukemia differentially affects circulating T(C)1, T(H)1, T(H)17 and T(REG )cells
por: Ersvaer, Elisabeth, et al.
Publicado: (2010) -
Future Perspectives: Therapeutic Targeting of Notch Signalling May Become a Strategy in Patients Receiving Stem Cell Transplantation for Hematologic Malignancies
por: Ersvaer, Elisabeth, et al.
Publicado: (2011) -
A Pilot Study of Circulating Monocyte Subsets in Patients Treated with Stem Cell Transplantation for High-Risk Hematological Malignancies
por: Rundgren, Ida Marie, et al.
Publicado: (2020) -
Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor
por: Melve, Guro Kristin, et al.
Publicado: (2016) -
Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target
por: Tvedt, Tor Henrik Anderson, et al.
Publicado: (2017)